Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1993 Jul;67(7):4432–4435. doi: 10.1128/jvi.67.7.4432-4435.1993

Identification of a region of the poliovirus genome involved in persistent infection of HEp-2 cells.

V Calvez 1, I Pelletier 1, S Borzakian 1, F Colbère-Garapin 1
PMCID: PMC237820  PMID: 8389941

Abstract

Poliovirus mutants were selected during the persistent infection of human neuroblastoma cells. These viruses could establish secondary persistent infections in HEp-2 nonneural cells. We report the identification of a region of the genome of a persistent virus (S11) that was sufficient to confer to a recombinant virus the phenotype that causes persistent infection in HEp-2 cells. This region, between nucleotides 1148 and 3481, contained 11 missense mutations mapping exclusively in the genes of capsid proteins VP1 and VP2. Because recombinant viruses carrying only one of these two mutated genes were not able to cause persistent infection, it seems very probable that two or more mutations in these genes are required for expression of the phenotype that causes persistent infection.

Full text

PDF
4434

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmed R., Hahn C. S., Somasundaram T., Villarete L., Matloubian M., Strauss J. H. Molecular basis of organ-specific selection of viral variants during chronic infection. J Virol. 1991 Aug;65(8):4242–4247. doi: 10.1128/jvi.65.8.4242-4247.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Borzakian S., Couderc T., Barbier Y., Attal G., Pelletier I., Colbère-Garapin F. Persistent poliovirus infection: establishment and maintenance involve distinct mechanisms. Virology. 1992 Feb;186(2):398–408. doi: 10.1016/0042-6822(92)90005-a. [DOI] [PubMed] [Google Scholar]
  3. Borzakian S., Pelletier I., Calvez V., Colbere-Garapin F. Precise missense and silent point mutations are fixed in the genomes of poliovirus mutants from persistently infected cells. J Virol. 1993 May;67(5):2914–2917. doi: 10.1128/jvi.67.5.2914-2917.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brahic M., Bureau J. F., McAllister A. Genetic determinants of the demyelinating disease caused by Theiler's virus. Microb Pathog. 1991 Aug;11(2):77–84. doi: 10.1016/0882-4010(91)90001-q. [DOI] [PubMed] [Google Scholar]
  5. Christodoulou C., Colbere-Garapin F., Macadam A., Taffs L. F., Marsden S., Minor P., Horaud F. Mapping of mutations associated with neurovirulence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperature. J Virol. 1990 Oct;64(10):4922–4929. doi: 10.1128/jvi.64.10.4922-4929.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Colbère-Garapin F., Christodoulou C., Crainic R., Pelletier I. Persistent poliovirus infection of human neuroblastoma cells. Proc Natl Acad Sci U S A. 1989 Oct;86(19):7590–7594. doi: 10.1073/pnas.86.19.7590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. DANIELS J. B., PAPPENHEIMER A. M., RICHARDSON S. Observations on encephalomyelitis of mice (DA strain). J Exp Med. 1952 Dec;96(6):517–530. doi: 10.1084/jem.96.6.517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Davis L. E., Bodian D., Price D., Butler I. J., Vickers J. H. Chronic progressive poliomyelitis secondary to vaccination of an immunodeficient child. N Engl J Med. 1977 Aug 4;297(5):241–245. doi: 10.1056/NEJM197708042970503. [DOI] [PubMed] [Google Scholar]
  9. Díez J., Dávila M., Escarmís C., Mateu M. G., Dominguez J., Pérez J. J., Giralt E., Melero J. A., Domingo E. Unique amino acid substitutions in the capsid proteins of foot-and-mouth disease virus from a persistent infection in cell culture. J Virol. 1990 Nov;64(11):5519–5528. doi: 10.1128/jvi.64.11.5519-5528.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fagan E., Yousef G., Brahm J., Garelick H., Mann G., Wolstenholme A., Portmann B., Harrison T., Mowbray J. F., Mowat A. Persistence of hepatitis A virus in fulminant hepatitis and after liver transplantation. J Med Virol. 1990 Feb;30(2):131–136. doi: 10.1002/jmv.1890300210. [DOI] [PubMed] [Google Scholar]
  11. Fricks C. E., Hogle J. M. Cell-induced conformational change in poliovirus: externalization of the amino terminus of VP1 is responsible for liposome binding. J Virol. 1990 May;64(5):1934–1945. doi: 10.1128/jvi.64.5.1934-1945.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Jubelt B., Ropka S. L., Goldfarb S. J., Janavs J. L. Anti-thymocyte serum delays clearance of poliovirus from the mouse central nervous system. J Neuroimmunol. 1989 May;22(3):223–232. doi: 10.1016/0165-5728(89)90020-9. [DOI] [PubMed] [Google Scholar]
  13. Kirkegaard K. Mutations in VP1 of poliovirus specifically affect both encapsidation and release of viral RNA. J Virol. 1990 Jan;64(1):195–206. doi: 10.1128/jvi.64.1.195-206.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kitamura N., Semler B. L., Rothberg P. G., Larsen G. R., Adler C. J., Dorner A. J., Emini E. A., Hanecak R., Lee J. J., van der Werf S. Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature. 1981 Jun 18;291(5816):547–553. doi: 10.1038/291547a0. [DOI] [PubMed] [Google Scholar]
  15. Klingel K., Hohenadl C., Canu A., Albrecht M., Seemann M., Mall G., Kandolf R. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):314–318. doi: 10.1073/pnas.89.1.314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kohara M., Abe S., Kuge S., Semler B. L., Komatsu T., Arita M., Itoh H., Nomoto A. An infectious cDNA clone of the poliovirus Sabin strain could be used as a stable repository and inoculum for the oral polio live vaccine. Virology. 1986 May;151(1):21–30. doi: 10.1016/0042-6822(86)90100-5. [DOI] [PubMed] [Google Scholar]
  17. Lapin B. A., Shevtsova Z. V. Persistence of spontaneous and experimental hepatitis A in rhesus macaques. Exp Pathol. 1990;39(1):59–60. doi: 10.1016/s0232-1513(11)80223-9. [DOI] [PubMed] [Google Scholar]
  18. Martin A., Wychowski C., Couderc T., Crainic R., Hogle J., Girard M. Engineering a poliovirus type 2 antigenic site on a type 1 capsid results in a chimaeric virus which is neurovirulent for mice. EMBO J. 1988 Sep;7(9):2839–2847. doi: 10.1002/j.1460-2075.1988.tb03140.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Miller J. R. Prolonged intracerebral infection with poliovirus in asymptomatic mice. Ann Neurol. 1981 Jun;9(6):590–596. doi: 10.1002/ana.410090613. [DOI] [PubMed] [Google Scholar]
  20. Moss E. G., Racaniello V. R. Host range determinants located on the interior of the poliovirus capsid. EMBO J. 1991 May;10(5):1067–1074. doi: 10.1002/j.1460-2075.1991.tb08046.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Murray M. G., Bradley J., Yang X. F., Wimmer E., Moss E. G., Racaniello V. R. Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site I. Science. 1988 Jul 8;241(4862):213–215. doi: 10.1126/science.2838906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Pelletier I., Couderc T., Borzakian S., Wyckoff E., Crainic R., Ehrenfeld E., Colbere-Garapin F. Characterization of persistent poliovirus mutants selected in human neuroblastoma cells. Virology. 1991 Feb;180(2):729–737. doi: 10.1016/0042-6822(91)90086-q. [DOI] [PubMed] [Google Scholar]
  23. Salvato M., Borrow P., Shimomaye E., Oldstone M. B. Molecular basis of viral persistence: a single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence. J Virol. 1991 Apr;65(4):1863–1869. doi: 10.1128/jvi.65.4.1863-1869.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Sharief M. K., Hentges R., Ciardi M. Intrathecal immune response in patients with the post-polio syndrome. N Engl J Med. 1991 Sep 12;325(11):749–755. doi: 10.1056/NEJM199109123251101. [DOI] [PubMed] [Google Scholar]
  25. Vallbracht A., Hofmann L., Wurster K. G., Flehmig B. Persistent infection of human fibroblasts by hepatitis A virus. J Gen Virol. 1984 Mar;65(Pt 3):609–615. doi: 10.1099/0022-1317-65-3-609. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES